Research news

Exenatide-PD3 results published

The full results of the Exenatide-PD3 study, a phase 3 clinical trial of Type 2 diabetes drug exenatide (Bydureon), have now been published. They report that the study unfortunately did not meet its primary or secondary endpoints. The full results of the Exenatide-PD3 study have…


News Fundraising news

Remembering a loved one with in memory giving

Honouring a loved one’s memory through charitable giving is a deeply meaningful way to celebrate their life and make a lasting difference. In memory donations not only pay tribute to someone special but also provide crucial support for our work to find a cure for…


Cure Parkinson's news

Prioritising the most promising drugs for Parkinson’s: our new drug screening project

Cure Parkinson’s is excited to announce funding for a pre-clinical project that aims to test, evaluate and compare drugs that have the potential to slow Parkinson’s progression. Established by Cure Parkinson’s, in collaboration with Van Andel Institute (VAI), the International Linked Clinical Trials (iLCT) committee…


News Fundraising news

Limited edition album ‘Think Loud’ to support Cure Parkinson’s

Music legends from the worlds of rock and folk have come together to create an exclusive double album to help raise funds and awareness for Cure Parkinson’s. Kindred Spirit have teamed up with musicians including Leo Sayer, John Cooper Clarke and Richard Thompson to create…


News Fundraising news

Cure Parkinson’s Fundraising Heroes: December 2024

2024 was a phenomenal year of fundraising for Cure Parkinson’s, and we’d like to say a huge thank you to everyone who helped raise vital funds and awareness for our research! We can’t wait to see what you – our incredible supporters – will do…